Launched in Southampton, the three-year scheme is a collaboration between the University of Southampton and Keele.

Scientists have pinpointed the cause of a debilitating back problem that affects thousands, leading to hope that it could pave the way for new treatments. Until now the exact driver of axial ...

Recently, researchers in Australia tested baricitinib, a drug used for rheumatoid arthritis, in people newly diagnosed with ...

Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.

Patients with D2T-PsA can be stratified into inflammatory and noninflammatory phenotypes, with the former linked to higher sonographic activity.

Back pain is rarely “just back pain.” Research shows it often comes with heart disease, arthritis, depression, or other chronic illnesses.

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® ...

When it comes to low impact fitness activities, walking and jogging are something most of us can do, without too much effort.

Delaying MTX initiation by 4 weeks after PCV13 vaccination significantly improved humoral responses in patients with RA, without compromising disease control.

And find out whether glucosamine supplements, joint braces and cushioned running shoes are worth splurging on to protect your joints.

Gout was associated with a 30% higher risk for chronic opioid exposure based on US Veteran's Health Administration data. Patients with gout in the United States are at greater risk for chronic opioid ...

Patients with systemic lupus erythematosus (SLE) and type 2 diabetes, with and without lupus nephritis (LN), had a lower risk ...